Seeing that the workers were quiet and most of them were thinking, Chen Xia continued to cheer and shout:

"So, Xiangjiang merchants are actually buying a pharmaceutical factory, which is the same as Bethune who came to China to help us defeat the reactionaries. Don't forget that my grandfather and aunt are also from Yuezhou. When the fellow villagers meet their fellow villagers, they will bear their backs... Oh, of course, they will not cheat our fellow villagers."

At this time, someone below shouted again: "Secretary Chen, how can you be sure that people from Xiangjiang are willing to pay high wages?"

"I can be sure of paying high wages, and I use my reputation as a guarantee. As long as I stay in the new company and work hard, the basic salary of workers will not be less than 50 yuan per month. The new company will also set up bonuses. Yes, there are bonuses in addition to the salary, but this bonus is more labor and more rewards. In the future, it will no longer be a big pot meal, but it will be the same as doing more and doing less.

In addition, the ugly saying goes first, I know that some people in pharmaceutical factories are not honest and don’t want to work and make trouble all day long. In our agreement with the region, it is particularly stated that the new company has the right to fire these employees.

So while the personnel relationship has not been frozen, if you have any relationship, you will find the relationship and transfer it to other factories. Otherwise, if you don’t do well then you will not be able to get rid of the matter with a few words of criticism.”

As soon as these words came out, everyone had their own plans.

Most people have been convinced, yes, they are so poor that they can be lost? Can a working-class identity be used as a meal?

Although Yuezhou textile mills are also half-stopped, their workers have the skills to earn extra money from township enterprises.

But there are only a few pharmaceutical factories in Yuezhou, and everyone’s life is similar, so they have nowhere to make extra money if they have pharmaceutical technology. This industry is really special.

Now that I have the opportunity to work in a foreign-funded enterprise, what else can I say? Just work hard. As long as I can earn as much as Qingfeng Pharmaceutical Factory, they are completely satisfied.

Like the north, workers strongly resist the transformation of enterprises, but it has not happened. It has to be said that Yuezhou people are still very adaptable, and Yuezhou masters will never go to extremes in doing things.

In this way, the Xiangjiang team took over Yuezhou Pharmaceutical Factory as quickly as possible.

The region is still very powerful this time, and all retired workers are divested, including those who want to leave early.

In addition, some employees chose to transfer jobs, including the vast majority of factory leaders and some related workers, who searched for relationships and went to other state-owned factories to continue their life.

Chen Xia was secretly happy for a long time when these people took the initiative to move away, otherwise he would have tried his best to drive these old men away.

The Yuezhou Pharmaceutical Factory has a direct relationship with this group of incompetent factory leaders and individual thorns.

The remaining workers include Ye Xin, the Minister of the Pumpkin Vine Human Resources Department, who began regular pre-job training. These workers have a certain level of education and most of them have rich experience in pharmaceuticals. After training, they can get on duty quickly.

As for Ye Shirong, he began to carry out comprehensive renovation of the factory area, and the construction requirements of the pharmaceutical production workshop have a strict set of standards.

Chen Xia’s requirement is to be modern and no longer have small-scale quarrels like Qingfeng Pharmaceutical Factory, so the vigorous infrastructure has also begun.

Everything is moving in the good direction.

Let’s leave professional matters to professionals. Chen Xia was a doctor in his previous life, not an entrepreneur, nor a pharmacy researcher, so he was not of much use except for making mistakes.

As a professional doctor, he has important things to do.

In the past two months, the Lancet magazine has published two serialized papers.

The fourth paper "Research on Clinical Treatment of Helicobacter pylori Infection", the first author is Chen Chun, the second author is Xuan Yongda, and the communication author is Chen Xia.

The fifth paper "Research Progress and Clinical Application Evaluation of Proton Pump Inhibitors", the first author is Zheng Haisheng, the second author is Wang Yiqun, and the Communication Author is Chen Xia.

These two papers are actually sister chapters, and the main content is that it clearly proposes that quadruple therapy can cure Helicobacter pylori and the cure rate reaches an astonishing 90%.

And the new pharmaceutical concept of proton pump inhibitor has been officially launched, focusing on the introduction of the first generation of product "Omeprazole".

"The Lancet" published five papers in less than a year. This method of breaking the rules naturally attracted strong attention from the mainstream medical community in the international world.

Chen Xia's role in "doubled the US dollar" is fully utilized.

The 5 papers are just 1 million US dollars. You should know that at this time, ordinary European and American workers only earn 10,000 US dollars a year. It is difficult to make the devil push in any country.

What? Bottom line? Isn’t the bottom line just used to break it?

If the first three papers are limited to academic research, the content of the fourth and fifth papers is directly clinical treatment, which is very meaningful.

There are many papers that propose some medical research directions every year, but few of them propose treatment plans, or even those that cannot be treated, which will attract much less attention.

For example, if you discover gastric cancer, then you study the pathogenic factors, pathophysiology, etc. of gastric cancer in detail. Everyone took a look: Oh, it turns out that this is how gastric cancer comes from. I understand, but I don’t feel shocked in my heart.

But one day, someone announced that he had developed a drug or surgery to cure gastric cancer, which was definitely a big news that caused a sensation in the world.

Doctors all know that the most common diseases in gastroenterology, such as gastritis, peptic ulcers, reflux esophagitis, etc., are all caused by excessive secretion of gastric acid, and even the occurrence of gastric cancer may have a certain relationship.

But even though I know, there is no way to cure it. I can only watch the patient's condition continues to worsen.

Now someone suddenly tells you that they have invented a treatment plan that can not only inhibit excessive secretion of gastric acid, but also kill a pathogenic bacillus in gastric acid. Can this not shock everyone?

These concepts, treatment plans, and new drugs are all international firsts.

Now, these five papers by Chen Chun and Zheng Haisheng are completely one-stop, from discovery to pathogenicity, and then to how to treat them, and of course they have attracted great attention from the international medical community.

Although everyone still doubts, or doubts are more important than beliefs, the authority of "The Lancet" forced them to believe it, and many people in the mainstream medical community began to want to come and conduct a field investigation.

Some large international drug dealers are also starting to get ready. If gastritis, peptic ulcers, esophageal reflux, etc. are really cured as mentioned in the paper, then this is a huge business opportunity.

In the early 1980s, the market for drug treatment of stomach diseases alone reached tens of billions of dollars. If it can be cured, the market would reach more than tens of billions of dollars, and everyone would not be moved.
Chapter completed!